JSJunjun Shao

Junjun Shao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Junjun Shao has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Huiyun Chang

    State Key Laboratory for Animal Disease Control and Prevention, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu, China

    13 shared publications
  • Wei Liu

    State Key Laboratory of Animal Disease Control and Prevention, Gansu Province Research Center for Basic Disciplines of Pathogen Biology, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu, 730046, China

    8 shared publications
  • Wei Liu

    State Key Laboratory for Animal Disease Control and Prevention, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China

    7 shared publications
  • Guanglei Zhang

    State Key Laboratory for Animal Disease Control and Prevention, Gansu Province Research Center for Basic Disciplines of Pathogen Biology, OIE/China National Foot-and-Mouth Disease Reference Laboratory, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu Province, China

    6 shared publications
  • Sicheng Yang

    State Key Laboratory for Animal Disease Control and Prevention, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China

    6 shared publications
  • Shandian Gao

    State Key Laboratory of Animal Disease Control and Prevention, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China

    5 shared publications

Latest Publications

  • Open Access

    A bioluminescence immunosensor using engineered antibody for quantitative detection of African swine fever virus

    by Wei Liu, Shandian Gao, Decai Peng, Jiaoyan Su, Jinshu Sui, Shenghui Wen, Tong Zhou, Huichen Guo, Junjun Shao, Huiyun Chang

  • Open Access

    Identification of efficient multi-epitope combinations against African swine fever virus based on AP205 scaffold-mediated nanodisplay technology

    by Haiyan Lu, Junjun Shao, Wei Liu, Shandian Gao, Huichen Guo, Hu Dong, Tong Zhou, Jian Yang, Huiyun Chang

    African swine fever virus (ASFV), characterized by its large genome and high antigenic diversity, has impeded the development of traditional vaccines. In this study, we employed the AP205 capsid protein as the scaffold to prepare ASFV multi-epitope nanoparticles via sequential steps: fusion of the scaffold gene with ASFV multi-epitope genes, followed by recombinant protein expression, purification, in vitro self-assembly, structural characterization, and immune evaluation in BALB/c mice. It was found that the dimeric AP205 scaffold enhanced the assembly efficiency of nanoparticles harboring epitopes of ASFV, and the recombinant proteins DB, 22C, and DE, fused with the scaffold and the epitopes, all formed virus-like particles (VLPs). Immunization experiments demonstrated that DE, which carries the linear B-cell epitopes pB438L 51-73, p72 244-262, and p54 132-180, exhibited the optimal immunological efficacy, with outstanding performance in immunoreactivity, immunogenicity, specific antibody titers, immune cell activation, and inhibition of ASFV nucleic acid replication by immune serum. The nanoparticle DF (carrying linear B-cell epitopes p17 5-34, 71-113, and p30 4-15) showed comparable or even superior efficacy in all aspects except for slightly lower antibody levels, while DB (carrying linear B-cell epitopes p17 68-86, pE248R 138-168, 158-185) and 22C (carrying linear B-cell epitopes pE120R 65-117, pE199L 175-189, pO61R 36-56) yielded moderate efficacy. The dimeric AP205 scaffold tolerates the insertion of exogenous antigen fragments with greater complexity and size, and its simplified fusion display strategy facilitates commercial production. The spatial structure of VLPs confers significant advantages in inducing efficient immune responses. Furthermore, the VLP structures designed and validated in this study provide valuable data for amino acid deconstruction of analogous architectures. Meanwhile, this study identified efficient and precise ASFV epitope combinations, providing informative data to support the application of ASFV multi-epitope nanoparticle vaccines.


  • Open Access

    Molecular Mechanism of VSV-Vectored ASFV Vaccine Activating Immune Response in DCs

    by Yunyun Ma, Junjun Shao, Wei Liu, Shandian Gao, Guangqing Zhou, Xuefeng Qi, Huiyun Chang

    The vesicular stomatitis virus (VSV)-vectored African swine fever virus (ASFV) vaccine can induce efficient immune response, but the potential mechanism remains unsolved. In order to investigate the efficacy of recombinant viruses (VSV-p35, VSV-p72)-mediated dendritic cells (DCs) maturation and the mechanism of inducing T-cell immune response, the functional effects of recombinant viruses on DC activation and target antigens presentation were explored in this study. The results showed that surface-marked molecules (CD80, CD86, CD40, and MHC-II) and secreted cytokines (IL-4, TNF-α, IFN-γ) were highly expressed in the recombinant virus-infected DCs. In addition, the co-culture results of recombinant virus-treated DCs with naive T cells showed that the Th1- and Th17-type responses were effectively activated. Taken together, the study indicated that the VSV-vectored ASFV vaccine activated the maturation of DCs and the Th1- and Th17-type immune response, which provided a theoretical basis for the development of novel ASF vaccines.

  • Open Access

    Discovery of a Structurally Stable Immunodominant Region in ASFV p30 C‐Terminus Using a Panel of Monoclonal Antibodies

    by Wei Liu, Shandian Gao, Jiaoyan Su, Jinshu Sui, Tong Zhou, Jian Yang, Haiyan Lu, Huichen Guo, Junjun Shao, Huiyun Chang

    African swine fever (ASF) is a lethal hemorrhagic viral disease of pigs with devastating global socioeconomic impacts. Due to the absence of a safe and effective vaccine, early surveillance and precise diagnostics are critical for ASF prevention and control. The ASF virus (ASFV) p30 protein, one of the most immunogenic early‐expressed antigens during infection, is a prime target for diagnostic assays and subunit vaccines. Its comprehensive antigenic characterization remains crucial for rational vaccine design. In this study, we generated a panel of 20 monoclonal antibodies (MAbs) against the ASFV p30 protein, classifying them into 11 groups based on epitope specificity. MAbs from six groups (subgroups I‐1, I‐2, and II‐1, as well as groups III, IV, and V, collectively comprising 15 MAbs) recognized six distinct epitopes within the C‐terminus of p30 (137–194 aa), while MAb 16‐5E7E8 (subgroup II‐2) recognized a distinct epitope within residues 154–190. The p30 C‐terminus (137–194 aa) demonstrated structural stability under denaturing conditions (SDS–PAGE and western blot [WB]) and was identified as an immunodominant region through its reactivity with ASFV‐positive sera. Notably, MAbs targeting this immunodominant region exhibited modest neutralizing activity, whereas those binding to other regions showed no neutralizing activity. Furthermore, MAb Q4‐1F10B7 (group VI) recognized a linear epitope “ 116 TSSFETLFEQ 125 ,” MAbs Q1‐1G4B2 (group VIII) and Q8‐4F9F3 (group IX) recognized conformation‐dependent epitopes, and MAb 5‐1C8B6 (group VII) likely recognized an aberrant or non‐native form of the p30 protein. These results expand the epitope landscape of p30 protein and lay a foundation for ASF diagnosis and vaccine research.


  • Dendritic cell-based biomimetic nanoparticles for foot-and-mouth disease induce robust cellular immunity

    by Zhan Gao, Xiaoqing Liu, Yao Lei, Junjun Shao, Guanglei Zhang, Zhuo Hou, Guangqing Zhou, Jin'EN Wu, Huichen Guo, Huiyun Chang, et al.


  • Open Access

    Screening and identification of linear B-cell epitopes on structural proteins of African Swine Fever Virus

    by Haiyan Lu, Junjun Shao, Wei Liu, Shandian Gao, Guangqing Zhou, Xiaoyu Ning, Haiyan Huang, Yijia Liu, Huiyun Chang


  • Open Access

    Molecular Mechanism of VSV Recombinant ASFV Antigen Gene Activating Immune Response of DCs in Mice

    by Yunyun Ma, Wei Liu, Shandian Gao, Guangqing Zhou, Junjun Shao, Xuefeng Qi, Huiyun Chang

    The VSV recombinant ASFV antigen gene live vector vaccines can induce efficient immune response, but the detailed mechanism remains unsolved yet. In order to investigate the efficacy of recombinant viruses (VSV-p35, VSV-p72) mediated dendritic cells (DCs) maturation and the mechanism of inducing T cells immune response, the functional effects of recombinant viruses to DCs activation and target antigens presentation were explored in this study. The results showed that surface marked molecules (CD80, CD86, CD40, and MHC-II) and secreted cytokines (IL-4, TNF-α, IFN-γ) were highly expressed in DCs that treated with recombinant viruses. The mixed lymphocyte reaction experiment results showed that the naive lymphocytes and polarized the CD4+T lymphocytes towards Th1 and Th17 cells were effectively activated when DCs were treated with recombinant viruses. In conclusion, the study indicated that VSV recombinant ASFV antigen gene live vector vaccine activated the maturation of DCs and the Th1 and Th17 type immune response, which provided a theoretical basis for the development of novel ASF vaccines.

  • Open Access

    Development of plate-type and tubular chemiluminescence immunoassay against African swine fever virus p72

    by Chun Miao, Junjun Shao, Sicheng Yang, Shenghui Wen, Yunyun Ma, Shandian Gao, Huiyun Chang, Wei Liu

    African swine fever (ASF) is a highly contagious and fatal viral disease that has caused huge economic losses to the pig and related industries worldwide. At present, rapid, accurate, and sensitive laboratory detection technologies are important means of preventing and controlling ASF. However, because attenuated strains of African swine fever virus (ASFV) are constantly emerging, an ASFV antibody could be used more effectively to investigate the virus and control the disease on pig farms. The isolation of ASFV-specific antibodies is also essential for the diagnosis of ASF. Therefore, in this study, we developed two chemiluminescence immunoassays (CLIAs) to detect antibodies directed against ASFV p72: a traditional plate-type blocking CLIA (p72-CLIA) and an automatic tubular competitive CLIA based on magnetic particles (p72-MPCLIA). We compared the diagnostic performance of these two methods to provide a feasible new method for the effective prevention and control of ASF and the purification of ASFV. The cut-off value, diagnostic sensitivity (Dsn), and diagnostic specificity (Dsp) of p72-CLIA were 40%, 100%, and 99.6%, respectively, in known background serum, whereas those of p72-MPCLIA were 36%, 100%, and 99.6%, respectively. Thus, both methods show good Dsn, Dsp, and repeatability. However, when analytical sensitivity was evaluated, p72-MPCLIA was more sensitive than p72-CLIA or a commercial enzyme-linked immunosorbent assay. More importantly, p72-MPCLIA reduced the detection time to 15 min and allowed fully automated detection. In summary, p72-MPCLIA showed superior diagnostic performance and offered a new tool for detecting ASFV infections in the future. Key points: • Two chemiluminescence immunoassay (plate-type CLIA and tubular CLIA) methods based on p72 monoclonal antibody (mAb) were developed to detect ASFV antibody. • Both methods show good diagnostic performance (Dsn (100%), Dsp (99.6%), and good repeatability), and p72-MPCLIA detects antibodies against ASFV p72 with high efficiency in just 15 min.


  • A recombinant multi-epitope trivalent vaccine for foot-and-mouth disease virus serotype O in pigs

    by Junjun Shao, Wei Liu, Shandian Gao, Huiyun Chang, Huichen Guo


  • Open Access

    Evaluation of humoral and cellular immune responses induced by a cocktail of recombinant African swine fever virus antigens fused with OprI in domestic pigs

    by Guanglei Zhang, Wei Liu, Sicheng Yang, Shuai Song, Yunyun Ma, Guangqing Zhou, Xiaxia Liang, Chun Miao, Junhui Li, Yanhong Liu, et al.

    Background: African swine fever (ASF) is a highly fatal disease in domestic pigs caused by ASF virus (ASFV), for which there is currently no commercial vaccine available. The genome of ASFV encodes more than 150 proteins, some of which have been included in subunit vaccines but only induce limited protection against ASFV challenge. Methods: To enhance immune responses induced by ASFV proteins, we expressed and purified three fusion proteins with each consisting of bacterial lipoprotein OprI, 2 different ASFV proteins/epitopes and a universal CD4+ T cell epitope, namely OprI-p30-modified p54-TT, OprI-p72 epitopes-truncated pE248R-TT, and OprI-truncated CD2v-truncated pEP153R-TT. The immunostimulatory activity of these recombinant proteins was first assessed on dendritic cells. Then, humoral and cellular immunity induced by these three OprI-fused proteins cocktail formulated with ISA206 adjuvant (O-Ags-T formulation) were assessed in pigs. Results: The OprI-fused proteins activated dendritic cells with elevated secretion of proinflammatory cytokines. Furthermore, the O-Ags-T formulation elicited a high level of antigen-specific IgG responses and interferon-γ-secreting CD4+ and CD8+ T cells after stimulation in vitro. Importantly, the sera and peripheral blood mononuclear cells from pigs vaccinated with the O-Ags-T formulation respectively reduced ASFV infection in vitro by 82.8% and 92.6%. Conclusions: Our results suggest that the OprI-fused proteins cocktail formulated with ISA206 adjuvant induces robust ASFV-specific humoral and cellular immune responses in pigs. Our study provides valuable information for the further development of subunit vaccines against ASF.